MGIC Investment Corporation reports Q2 results on July 30 with a notable divergence at its core: the stock has rallied 5% on the week and nearly 10% over the past month, yet virtually everyone with direct knowledge of the company has been selling into that strength.
The insider selling pattern is the most compelling angle heading into earnings. The President/COO alone sold 60,000 shares across two transactions in June and July, netting roughly $1.6 million at prices between $28.23 and $25.38. The CFO sold 20,000 shares on June 25 at $27.10. The CEO sold 139,202 shares in early April for nearly $3.7 million. Net of awards, aggregate insider activity over the past 90 days amounts to a positive 240,000 shares on paper — but that figure is inflated by a large equity award grant with zero dollar value. The cash-transacted selling tells a cleaner story: senior management has been reducing exposure consistently as the stock climbs.
Short positioning and borrow conditions offer no meaningful counterweight to the rally. Short interest has pulled back sharply — down 6.4% on the week to 4.2% of the free float — and the lending market is almost entirely unconstrained, with availability running above 5,300%, well into the loosest territory of the past year. Borrowing costs are negligible at 0.43%. This is not a stock where short sellers are pressing an aggressive thesis; the reduction in shorts into strength suggests the bear case is being covered, not built. The ORTEX short score sits at 41, broadly neutral and drifting lower through the week.
Options positioning has shifted meaningfully and is worth reading carefully. The put/call ratio has collapsed to 1.21, roughly 1.4 standard deviations below its 20-day mean of 25.3. That extreme compression looks technical — the prior 20-day window included weeks of very heavy put-dominated activity, and a sharp rotation toward calls or a drop in open put interest can mechanically drag the ratio down. On balance, the current reading points to far less downside hedging than has been typical over the past month, which aligns with a market that has been buying the stock ahead of the print rather than protecting against it.
The Street is unconvinced by the rally. The analyst consensus is a clean Hold from three firms, with a mean price target of $28.80 — roughly 6% below current levels at $30.58. The most recent coverage action, RBC Capital's initiation at Sector Perform with a $28 target in late May, came in below where the stock trades today. Barclays trimmed its target to $28 post the April earnings miss. That April print was severe: MTG fell 9.9% the day results dropped and was still down 8.8% five days later. The stock has since fully recovered and then some, but the Street has not moved its targets to reflect that recovery. Valuation is creeping up — the price/book multiple has expanded roughly 0.10x over the past 30 days to 1.14x, and the trailing P/E has risen to 9.6x — but EPS momentum scores in the 29th-32nd percentile, and the 12-month forward earnings growth outlook has been under sustained pressure.
The clearest question for the July 30 print is whether MTG can avoid a repeat of April's sharp post-earnings drop, given that the stock is entering the release at its highest level in months, with insiders having sold aggressively into that appreciation, the Street holding firm below current prices, and the only recent earnings data point showing a near-10% one-day loss on disappointing results.
See the live data behind this article on ORTEX.
Open MTG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
